APAC Electrophysiology Market

APAC Electrophysiology Market Size (2022 to 2027)

As per the research report, the Asia Pacific Electrophysiology Market size has been calculated at USD 1.66 billion in 2022. It is estimated to be growing at a CAGR of 10.54% and worth USD 2.74 billion by 2027.

Electrophysiology can be defined as the study of electrical properties in biological tissues and cells. It measures changes in electrical currents and voltages across systems varying from single ion protein channels to complete organs like the heart.

In this field, the most commonly used modalities are electrocardiography, which involves measuring the electrical activity of the brain, and electromyography, which measures the electrical activity in the skeletal muscles. Other modalities in which this science is used are intracardiac electrogram, electroretinography, electrooculography, electronystagmography, electrocorticography, and electrogastrography.

The market for APAC electrophysiology is expected to be driven by the expanding elderly population, the development of technologically improved electrophysiology devices, the rising incidence of arrhythmia around the region, and the rising need for catheter ablation operations, among other factors. 

In addition, the growing population, rising incidence of chronic diseases, new market participants, expanding investments, funds, and grants, healthcare reforms for infrastructure development, rising demand for advanced technologies, prominent players’ growing emphasis on emerging markets, and less stringent regulations are all driving the Asia pacific electrophysiology market forward. 

Furthermore, the market is predicted to grow significantly throughout the forecast period, owing to the growing post-pandemic requirement for standardized practices to ensure maximum safety. In addition, the rising number of cases of heart failure and other target disorders is the key driver of market growth. At the same time, market growth is likely to be fueled by developments in electrophysiology technology and the growing demand for ablation catheter treatments.

Innovative technologies such as cryoablation, laser ablation, ultrasonic ablation, and enhanced mapping technologies are expected to increase the market over the forecast period. In addition, the increased prevalence of heart failure and cardiac arrest cases among millennials linked to lifestyle choices such as smoking and excessive alcohol consumption also propel the market. On the other hand, the Participants in the market prioritize producing advanced products, which is projected to boost the industry’s growth potential.

However, Factors such as a scarcity of competent electrophysiologists and adverse healthcare changes in some countries limit the market.

This research report on the Asia-Pacific Electrophysiology Market has been segmented and sub-segmented into the following categories:

By Product:                       

• Electrophysiology Diagnostic Catheters      

  • Advanced Electrophysiology Diagnostic Catheters

  • Conventional Electrophysiology Diagnostic Catheters

  • Ultrasound Electrophysiology Diagnostic Catheters

• Electrophysiology Ablation Catheters          

  • Radiofrequency (RF) Ablation Catheters

  • Cryoablation Electrophysiology Catheters

  • Laser Ablation Systems

  • Microwave Ablation Systems

  • Navigational Advanced Mapping Accessories

• Electrophysiology Laboratory Devices         

  • Electrophysiology Recording Systems

  • 3D Mapping Systems

  • Radiofrequency (RF) Ablation Generators

  • Electrophysiology X-Ray Systems

  • Intracardiac Echocardiography (ICE) Systems

  • Electrophysiology Remote Steering Systems

• Access Devices

By Indication:

• Atrial Flutter          

• Atrial Fibrillation  

• Wolff-Parkinson-White Syndrome

• Atrioventricular Nodal Re-entry Tachycardia          

• Other Indications

By Country: 

• India

• China

• Japan

• South Korea

• Australia

• New Zealand

• Thailand

• Malaysia

• Vietnam

• Philippines

• Indonesia

• Singapore

• Rest of APAC

In terms of geography, the Asia Pacific electrophysiology market shares the world’s third-largest market. Also, it is the fastest expanding region. The growing elderly population and technological improvements are projected to fuel the region’s market. The APAC electrophysiology market has high unmet medical requirements, and fast increasing targeted disease occurrence levels. The market is predicted to develop as healthcare infrastructure improves patient awareness and regional healthcare expenditure.

Asia, particularly China, Japan, and India, is likely to experience rapid expansion in the coming years. 

China accounted for the largest share of the Asia Pacific Electrophysiology market, and it is likely to continue its growth throughout the forecast period. The market growth is attributed to the growing population, healthcare sector technological advancements, and favorable reimbursement policies. On the other hand, growing health-related difficulties have emerged from lifestyle changes, dietary habits, and increased stress, smoking, and drinking. In addition, less government intervention is assisting the region’s demand for electrophysiological equipment. 

Japan in the APAC electrophysiology market has a market share of more than 22% in 2020. The presence of major industry players in the nation would have an impact on market growth. Furthermore, the country’s aging population, rising prevalence of cardiac arrhythmia, and widespread availability of modern products all contribute to the market’s potential. In addition, the growing popularity of less invasive procedures will boost the demand for electrophysiological procedures in Japan in the next years. In Japan, atrial fibrillation affects 2% to 3% of the elderly population. With the aging population, it is anticipated that one million people will suffer from atrial fibrillation by 2050, propelling the electrophysiology devices industry forward.

Some of the most promising companies dominating the APAC Electrophysiology Market profiled in the report are Boston Scientific Corporation (U.S.), GE Healthcare (U.K.), Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), Microport Scientific Corporation (China), St. Jude Medical, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (The Netherlands), Medtronic, Inc. (U.S.) and Siemens AG (Germany).